4//SEC Filing
Dahlquist Karl S. 4
Accession 0001323885-25-000019
CIK 0001323885other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:59 PM ET
Size
8.1 KB
Accession
0001323885-25-000019
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Dahlquist Karl S.
Chief Legal Officer
Transactions
- Award
Common Stock
2025-03-01+19,359→ 71,020 total - Award
Common Stock
2025-03-01+6,579→ 77,599 total - Tax Payment
Common Stock
2025-03-01$38.74/sh−9,870$382,364→ 67,729 total
Footnotes (3)
- [F1]The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant.
- [F2]The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met.
- [F3]The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001861996
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:59 PM ET
- Size
- 8.1 KB